当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析

以岭药业

(002603)

  

流通市值:194.69亿  总市值:236.24亿
流通股本:13.77亿   总股本:16.71亿

以岭药业(002603)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润3.24亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益1052619.37万元,未分配利润560631.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1369408.80万元,负债316789.43万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入2,358,232,707.776,512,734,471.776,365,441,001.174,604,485,816.89
营业总成本1,946,902,188.17,147,123,381.225,723,859,252.053,978,871,341.64
营业利润398,572,313.82-688,895,452.05703,133,763.23670,958,832.67
利润总额394,121,050.36-800,192,007.83672,108,390.61643,322,075.42
净利润324,155,914.76-734,183,532.26549,086,852.74526,626,374.89
其他综合收益-54,894.21-507,389.2551,883.7520,576.61
综合收益总额324,101,020.55-734,690,921.46549,638,736.49526,646,951.5
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计4,794,368,334.24,334,951,809.126,183,574,663.116,537,412,403.8
非流动资产合计8,899,719,678.68,984,219,279.1610,430,510,047.8710,414,113,796.31
资产总计13,694,088,012.813,319,171,088.2816,614,084,710.9816,951,526,200.11
流动负债合计2,661,153,079.612,606,688,892.163,937,753,312.34,374,366,278.1
非流动负债合计506,741,246.93510,389,530.411,190,689,0751,113,729,383.34
负债合计3,167,894,326.543,117,078,422.575,128,442,387.35,488,095,661.44
归属于母公司股东权益合计10,549,386,134.3110,223,487,732.2711,503,839,430.8711,478,988,389.47
股东权益合计10,526,193,686.2610,202,092,665.7111,485,642,323.6811,463,430,538.67
负债和股东权益合计13,694,088,012.813,319,171,088.2816,614,084,710.9816,951,526,200.11
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计2,180,849,648.917,579,873,914.435,600,361,187.313,986,854,237.47
经营活动现金流出小计1,840,752,541.56,968,860,743.325,277,731,356.233,722,687,357.56
经营活动产生的现金流量净额340,097,107.41611,013,171.11322,629,831.08264,166,879.91
投资活动现金流入小计280,127,334.144,155,824,627.632,146,354,236.062,006,096,063.16
投资活动现金流出小计478,507,141.732,543,790,861.82,146,469,910.381,867,976,571.02
投资活动产生的现金流量净额-198,379,807.591,612,033,765.83-115,674.32138,119,492.14
筹资活动现金流入小计-1,182,500,0001,047,716,733.33677,716,733.33
筹资活动现金流出小计293,7603,435,683,165.721,355,605,763.36766,595,483.81
筹资活动产生的现金流量净额-293,760-2,253,183,165.72-307,889,030.03-88,878,750.48
汇率变动对现金及现金等价物的影响81,373.65105,273.7-19,813.0145,043.94
现金及现金等价物净增加额141,504,913.47-30,030,955.0814,605,313.72313,452,665.51
期末现金及现金等价物余额958,108,087.87816,603,174.4861,239,443.21,160,086,794.99
最新报告期:2025-05-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰0.740.860.982025-05-05
华泰证券代雯,张云逸0.810.941.072025-05-02
TOP↑